LoginMy Member Benefitsarchivesresearchyour teamabout usFAQLog out
Money Morning Private Briefing
Private Briefing
with WILLIAM PATALON III, Executive Editor

Global Equity Markets Mostly Weaker; Euro Currency Rallies

Hot Topics
Share
Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

pharmaceutical stocks

Article Index

The 3 Best Pharmaceutical Stocks to Buy in 2017

By , Associate Editor, Money Morning -

Best Pharmaceutical Stocks to Buy in 2017

Our expert has developed a vetting process to identify the best pharmaceutical stocks to buy in 2017.

One of the stocks he picked using this set of guidelines is already up almost 60% year to date.

Here are the guidelines and the best stocks to buy now for major profits this year...

Top Pharmaceutical Stocks to Watch in May 2017

By , Associate Editor, Money Morning • @AlexMcGuire92 -

pharmaceutical stocks

The pharma sector has widely outperformed the broader market lately.

That's why we've made this list of the 10 top pharmaceutical stocks to watch in May 2017.

We're also including our pick for one of the best pharma stocks to buy this year. Check it out...

The Damning Link Between Mylan and the Clinton Foundation

By , Staff Writer, Money Morning -

Mylan

The Mylan scandal and the Clinton Foundation have a damning connection involving shoddy drug practices.

This just-released report contains all the evidence...

As The Markets Keep Dreaming, Listen for These Alarms

By , Global Credit Strategist, Money Morning • @MichaelELewitt -

emerging markets

Markets have no memory. So once again they are rallying based on false hopes that central bankers will save them from themselves.

Despite a stealth bear market in many stocks, the major indices have recovered all of their 2015 losses in October. They've been boosted by several factors - large cap tech stocks, expectations for a delay in Fed tightening, more European QE, and further interest rate cuts by an increasingly desperate China...Such are the stuff that dreams are made of in the terminal stages of one of the biggest bull markets in history.

As I've written before, I believe that bull market is over and we are now likely entering a bear market. There are too many macroeconomic headwinds to sustain further stock market gains.

The Chinese economic miracle is over. Commodity prices are not going to recover any time soon...

Pharmaceutical Companies Hike Prescription Prices 76% Since 2010

By , Associate Editor, Money Morning • @KyleAndersonMM -

pharma companies

Pharmaceutical companies have been raising the price of prescription drugs at an alarming rate since 2010.

According to a new report from The Wall Street Journal, the 30 highest-selling drugs in the United States saw their prices increase roughly 76% from 2010 through 2014.

And as they've raised prices, their profits have soared...

$30 Billion Deal Between Top Pharmaceutical Companies Is a Major Buy Signal

By , Associate Editor, Money Morning • @KyleAndersonMM -

Biotech Investing

Another possible deal between two of the world's top pharmaceutical companies was announced this week when Shire Plc. (Nasdaq: SHPG) made an unsolicited offer of $30.6 billion for Baxalta Inc. (NYSE: BXLT).

Money Morning Defense & Tech Specialist Michael A. Robinson has been following this trend since 2014. He knew the world's top pharmaceutical companies would continue their M&A binge, and he recommended an investment to play that wave.

Robinson's pick has already climbed 17.6% this year and still has plenty of room to run...

Why Pharmaceutical Stocks Are Crushing the Market [Chart]

By , Associate Editor, Money Morning • @KyleAndersonMM -

Biotech Investing

Pharmaceutical stocks have crushed the broader markets in 2015.

The S&P Pharmaceuticals Select Industry Index has climbed 20.9% year to date. In the last 12 months, the index has climbed 42.5%.

Here's how that compares to the broader markets...

[Chart] Pharma Companies Make Billions as Prescription Spending Soars

By , Associate Editor, Money Morning • @KyleAndersonMM -

Biotech Investing

Prescription drug spending continues to hit record highs, and the world's top pharma companies continue to bank billions.

More than $374 billion was spent on prescription drugs in the United States in 2014, according to a report from the IMS Institute of Health. That was a 13.1% jump from 2013, and the highest growth rate in more than a decade, says ExpressScripts.

Here's a look at how U.S. prescription drug spending has trended over the last 10 years..

The 5 Top Pharma Companies Behind the World's Most Expensive Drugs

By , Associate Editor, Money Morning • @KyleAndersonMM -

top pharma companies

The world's top pharma companies bring in billions in revenue every year, sometimes from only a few products.

That's the case with each of these top pharma companies. This chart shows the most expensive prescription drugs in the world. The most expensive drug, Soliris, costs each patient $409,500 every year.

Here are the seven most expensive drugs in the world:

This Merger of Top Pharmaceutical Companies Is a Major Profit Opportunity

By , Associate Editor, Money Morning • @KyleAndersonMM -

top pharmaceutical companies

Two top pharmaceutical companies announced a merger this morning, continuing 2015's massive run of M&A activity.

Botox maker Allergan Plc. (NYSE: AGN) announced today that it will purchase Kythera Biopharmaceuticals Inc. (Nasdaq: KYTH) for $2.1 billion. That values KYTH shares at $75 each - 24% higher than Tuesday's closing price.

The move highlights one of our favorite profit plays of 2015. It's up 16.7% already and has plenty of room to run...

Complete List of Pharmaceutical Companies with the Highest Revenue

By , Associate Editor, Money Morning • @KyleAndersonMM -

list of pharmaceutical companies

The pharmaceutical industry is one of the most profitable sectors in the world.

More than $978 billion was spent on prescription drugs in 2014, according to a report from ExpressScripts. That was a 13.1% jump from 2013.

And the biggest names in the pharmaceutical industry are bringing in billions annually. Here's the complete list of pharmaceutical companies by revenue in 2014...

This Pharmaceutical Industry Investment Plays a $166 Billion Trend

By , Associate Editor, Money Morning • @KyleAndersonMM -

pharmaceutical industry

The pharmaceutical industry saw record-setting M&A activity in the first quarter of 2015.

According to PricewaterhouseCoopers, the "life sciences" field had 35 deals in Q1 2015. Those deals totaled $166.3 billion. That's more money than was spent during the entire year in 2014, when $150.1 billion was spent. In Q1 2014, just $46.5 billion was spent.

Money Morning's Defense and Tech Specialist Michael Robinson has been recommending a way to profit from the M&A boom throughout 2015.

His pick has already climbed 12% in 2015, compared to just 2% for the Dow Jones. Here's why it will continue bringing profits in 2015...

Where a Teva-Mylan Deal Would Rank Among Big Pharma Companies

By , Associate Editor, Money Morning • @KyleAndersonMM -

big pharma companies

Two big pharma companies are in merger talks this week. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced Tuesday it's making a $40 billion bid for Mylan NV (Nasdaq: MYL).

Combined, the two firms would have revenue near $28 billion. That would make the company the ninth-largest pharmaceutical company in the world based on revenue.

Here's a look at the top 10 big pharma companies globally...

Top Pharmaceutical Companies Continue Massive M&A – Here's Your Profit Play

By , Associate Editor, Money Morning • @KyleAndersonMM -

Top pharmaceutical companies

Two of the world's top pharmaceutical companies have announced a merger today (Thursday), and that's another major buy signal for one of our favorite profit opportunities.

AbbVie Inc. (NYSE: ABBV) officials announced they will purchase Pharmacyclics Inc. (Nasdaq: PCYC) for roughly $21 billion.

 

The deal gives Abbvie access to one of the world's top-selling cancer drugs, Imbruvica. Revenue from Imbruvica alone is expected to hit $1 billion in 2015 and $5.8 billion by 2020.

These Pharmaceutical Stocks Let You Tap into a $402 Billion Trend

By , Associate Editor, Money Morning • @KyleAndersonMM -

pharmaceutical stocks

A sector of the pharmaceutical market known as "high-margin specialty drugs" is presenting us with the best pharmaceutical stocks to buy now.

According to experts at PricewaterhouseCoopers, consumer spending on high-margin specialty drugs hit $87.1 billion in 2012. In five years that number will quadruple to $401.7 billion.

The Wall Street Journal reports that total U.S. prescription drug spending was just $325.7 billion in 2012.

And those aren't the only alarming growth numbers boosting pharma stocks now...

Today's Markets
DJIA -98.89 (0.46%) 21,310.66
NASDAQ -100.53 (-1.61%) 6,146.62
S&P -19.69 (0.81%) 2,419.38